Related content

Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A

By Groen Emma J.   Charlton Richard   Barresi Rita   Anderson Louise V.   Eagle Michelle   Hudson Judith   Koref Mauro Santibanez   Straub Volker   Bushby Katharine M. D.  

Brain, Vol. 130, Iss. 12, 2007-12 ,pp. : 3237-3249

Oxford University Press

Access to resources Recommend Favorite

A phase I trial of adeno-associated virus serotype 1--sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C

By Herson Serge  

Brain, Vol. 135, Iss. 2, 2012-03 ,pp. : 483-492

Oxford University Press

Access to resources Recommend Favorite

A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy

By Hicks Debbie  

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 171-182

Oxford University Press

Access to resources Recommend Favorite

Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain)

By Urtasun M   Sáenz A   Roudaut C   Poza JJ   Urtizberea JA   Cobo AM   Richard I   García Bragado F   Leturcq F   Kaplan JC   Martí Massó JF   Beckmann JS   López de Munain A  

Brain, Vol. 121, Iss. 9, 1998-09 ,pp. : 1735-1747

Oxford University Press

Access to resources Recommend Favorite

A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of -dystroglycan

By Dincer P.   Balci B.   Yuva Y.   Talim B.   Brockington M.   Dincel D.   Torelli S.   Brown S.   Kale G.   Haliloglu G.   Gerceker F.O.   Atalay R.C.   Yakicier C.   Longman C.   Muntoni F.   Topaloglu H.  

Neuromuscular Disorders, Vol. 13, Iss. 10, 2003-12 ,pp. : 771-778

Elsevier

Access to resources Recommend Favorite